FTC starts investigation into mental-health start-up Cerebral
The US antitrust watchdog has issued a letter to the company that said the FTC was investigating whether…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
15 Jun 22
The US antitrust watchdog has issued a letter to the company that said the FTC was investigating whether…
14 Jun 22
Albrioza, also known as AMX0035, is an oral fixed-dose combination therapy that works to reduce neuronal cell death…
14 Jun 22
The FDA approval is supported by Lilly’s BRAVE-AA1 and BRAVE-AA2 clinical trials, which evaluated the efficacy and safety…
13 Jun 22
The company’s investigational RSV vaccine candidate RSVPreF3 OA has showed statistically significant and clinically meaningful efficacy in adults…
13 Jun 22
The US regulator required a patient notification about suicidal behaviour, where it has previously approved an expanded its…
10 Jun 22
The acquisition will provide Pfizer with ReViral’s portfolio of therapeutic candidates, including sisunatovir, along with another lead candidate,…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
09 Jun 22
The EC approval is based on positive results from the Phase ½ GO29781 study, which assessed the safety,…
09 Jun 22
As the new flagship depot for the European continent, the Dublin site will be an important global hub,…
08 Jun 22
The FDA approval is based on data from a Phase 3 trial which evaluated the efficacy and safety…
07 Jun 22
Given as two doses, the vaccine can also be administered as a second shot in individuals who previously…